Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy

Overview of attention for article published in Orphanet Journal of Rare Diseases, August 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Average Attention Score compared to outputs of the same age and source

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 6,409 followers.

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy https://t.co/iG054wLl7C https://t.co/aLo3X40zy7

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy. https://t.co/x5l3nLNEuK

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy. http://t.co/EMPeXyHPED

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy http://t.co/L9g6GaDM2B #Duchenne $COX

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.